It is cGMP certified and is able to produce for third parties in Europe and worldwide. It is regularly inspected and has been approved by many multinationals and leading pharmaceutical companies of the world.
Osmopharm manufactures pharmaceutical modified-release products in such a way that the contained active principles are dissolved into the gastro intestinal tract at a controlled speed. These active principles are marketed in bulk (mainly in pellets) or dosed in hard gelatine capsules or tablets.
Moreover, Osmopharm offers a full packaging department with blistering and cartonizing machinery in order to perform the final packaging of the finished pharmaceutical presentation, if required by the customer, as well as complete regulatory support.
Osmopharm SA
Osmopharm operates as a third-party contract manufacturer (CMO) of modified-release, solid pharmaceutical products of both generic and proprietary formulations.
Located in Bedano, approximately 10 km from Lugano, Osmopharm S.A. is authorised by the Swiss National Health Authority, Swissmedic, to produce medicinal not sterile solid specialities.
Activities
Main Activity
Licensing-In (Partial)
Development
Drug Product CMO
Drug development (Partial)
Analytical Services (Partial)
Micronization (Partial)
Pre-formulation
Other Activities (Partial)
Therapeutic Areas
Cardiology
Gastrointestinal
Gynaecology/Women's Health
Mental health
Pain
Respiratory
Urology
Markets
CH
EU Top 5
Rest of Europe
LATAM
MENA
BRICS
ASEAN
Drug Stages
Pre-clinical
Drug Product Forms
Oral (solid)
Certifications
Swissmedic
GMP
ESG Certifications & Collaborations
Ecovadis
